StockData
BioVie Inc. logo

BioVie Inc. (BIVI) stock

BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.00−0.08 (-7.84%)

Close on Nov 17, 2026Market cap $7.51MP/E –Yield –

BioVie total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioVie's total debt was $2.97M at Sep 30, 2023. For fiscal 2023 it was $5.23M, down 56.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Jun 30, 2023$5.23M-56.9%
FY2022Jun 30, 2022$12.14M+19321.9%
FY2020Jun 30, 2020$62.50K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2024CQ3 2023Sep 30, 2023$2.97M-76.7%
Q4 FY2023CQ2 2023Jun 30, 2023$5.23M-56.9%
Q3 FY2023CQ1 2023Mar 31, 2023$7.41M-36.3%
Q2 FY2023CQ4 2022Dec 31, 2022$13.26M+19.3%
Q1 FY2023CQ3 2022Sep 30, 2022$12.73M+20260.7%
Q4 FY2022CQ2 2022Jun 30, 2022$12.14M+19321.9%
Q3 FY2022CQ1 2022Mar 31, 2022$11.62M+18499.9%
Q2 FY2022CQ4 2021Dec 31, 2021$11.11M+17677.9%
Q3 FY2021CQ1 2021Mar 31, 2021$62.50K–
Q2 FY2021CQ4 2020Dec 31, 2020$62.50K–
Q1 FY2021CQ3 2020Sep 30, 2020$62.50K–
Q4 FY2020CQ2 2020Jun 30, 2020$62.50K–

More BioVie figures

See a number that looks wrong?